The CFIDS Association recently completed its spring review of research
grants and is pleased to announce the following studies have been approved
for funding beginning in July 2004:
HERV-K18 as a risk factor for CFIDS;
Brigitte Huber, PhD, Tufts
University School of Medicine, Boston, Ma.
Pilot study of the effects of
corticotrophin-releasing hormone (CRH) on cortisol and interleukin-6
concentrations, and adipose tissue interleukin-6 production in patients with
CFS;
Dimitris Papanicolaou, MD, Emory
University School of Medicine, Atlanta, Ga.
H MRS Neurometabolites as Diagnostic Markers for
Chronic Fatigue Syndrome;
Dikoma Shungu, PhD, Weill Medical College
of Cornell University, New York, N.Y.
Using an Exercise Challenge to Investigate the
Pathophysiology of CFIDS;
Christopher Snell, PhD and J. Mark Van Ness, PhD,
University of the Pacific, Stockton, Ca.
Support for these research projects will total $317,710 during
the grant term July 2004 – June 2005 – the most in pilot research funded since
1993. The Association is committed to maintaining the momentum of promising
CFIDS research. Thank you for your generous support of the Association's
research program.
Look for more information on the approved projects on our Web
site soon.
